drugset / Trial / NCT03255824

A Comparison of Dexmedetomidine Versus Propofol for Use in Intravenous Sedation

NCT03255824 ↗

Phase 4 Completed 144 enrolled Montefiore Medical Center
RandomizedParallel-groupDouble-blindOther

Summary

Hypothesis: A combination of midazolam with dexmedetomidine for sedation during third molar surgery will provide 1) superior patient satisfaction, 2) superior operator satisfaction and 3) no significant hemodynamic or respiratory changes when compared to a sedation combination of midazolam, fentanyl and propofol for sedation during third molar surgery.

Timeline

Start
2018-03-20
Primary completion
2019-08-23
Completion
2019-12-27

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified — Intravenous
Comparator Fentanyl Other / unclassified — Intravenous
Comparator Propofol Small molecule — Intravenous
Background Midazolam Small molecule — Intravenous

Indications

No indication recorded.